Number of the records: 1  

A local application of mesenchymal stem cells and cyclosporine A attenuates immune response by a switch in macrophage phenotype

  1. 1.
    SYSNO ASEP0454064
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleA local application of mesenchymal stem cells and cyclosporine A attenuates immune response by a switch in macrophage phenotype
    Author(s) Hájková, M. (CZ)
    Javorková, Eliška (UEM-P) RID
    Zajícová, Alena (UEM-P) RID
    Trošan, Peter (UEM-P)
    Holáň, Vladimír (UEM-P) RID
    Krulová, Magdaléna (UEM-P)
    Number of authors6
    Source TitleJournal of Tissue Engineering and Regenerative Medicine. - : Wiley - ISSN 1932-6254
    Roč. 11, č. 5 (2017), s. 1456-1465
    Number of pages10 s.
    Languageeng - English
    CountryGB - United Kingdom
    Keywordsmesenchymal stem cells ; cyclosporine A ; macrophages
    Subject RIVEB - Genetics ; Molecular Biology
    OECD categoryCell biology
    R&D ProjectsGAP304/11/0653 GA ČR - Czech Science Foundation (CSF)
    GAP301/11/1568 GA ČR - Czech Science Foundation (CSF)
    GA14-12580S GA ČR - Czech Science Foundation (CSF)
    NT14102 GA MZd - Ministry of Health (MZ)
    Institutional supportUEM-P - RVO:68378041
    UT WOS000402987500013
    EID SCOPUS84933574461
    DOI10.1002/term.2044
    AnnotationThe immunosuppressive effects of systemically administered mesenchymal stem cells (MSCs) and immunosuppressive drugs have been well documented. We analysed the mechanisms underlying the therapeutic effect of MSCs applied locally in combination with non-specific immunosuppression in a mouse model of allogeneic skin transplantation. The MSC-seeded and cyclosporine A (CsA)-loaded nanofibre scaffolds were applied topically to skin allografts in a mouse model and the local immune response was assessed and characterized. MSCs migrated from the scaffold into the side of injury and were detected in the graft region and draining lymph nodes (DLNs). The numbers of graft-infiltrating macrophages and the production of nitric oxide (NO) were significantly decreased in recipients treated with MSCs and CsA, and this reduction correlated with impaired production of IFN. in the graft and DLNs. In contrast, the proportion of alternatively activated macrophages (F4/80(+)CD206(+) cells) and the production of IL-10 by intragraft macrophages were significantly upregulated. The ability of MSCs to alter the phenotype of macrophages from the M1 type into an M2 population was confirmed in a co-culture system in vitro. We suggest that the topical application of MSCs in combination with CsA induces a switch in macrophages to a population with an alternatively activated 'healing' phenotype and producing elevated levels of IL-10. These alterations in macrophage phenotype and function could represent one of the mechanisms of immunosuppressive action of MSCs applied in combination with CsA.
    WorkplaceInstitute of Experimental Medicine
    ContactLenka Koželská, lenka.kozelska@iem.cas.cz, Tel.: 241 062 218, 296 442 218
    Year of Publishing2018
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.